Med-Tech Innovation April 19, 2024

ASPIVIX announces its partnership with Bayer (Schweiz) in Switzerland, aimed at transforming gynecological procedures.

The companies are introducing Carevix, a CE-Marked cervical stabiliser designed to minimise pain and bleeding during transcervical procedures, including IUD placement.

This Swiss collaboration combines Bayer (Schweiz)’s knowledge in contraceptive solutions with ASPIVIX’s commitment to modernising gynaecology.

The shared goal is to offer women a more comfortable and efficient gynaecological experience, reducing the cases of pain associated with IUD procedures.

The potential pain during IUD insertion impacts millions of women worldwide, largely due to the use of the century-old cervical tenaculum in gynaecological procedures.

Carevix,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Partnerships, Trends
Prioritizing Patient Care: Medical Technology Innovations on the Horizon
MHRA ‘sandbox’ to pilot AI regulation will go live soon
Medline to acquire surgical products business
Medline to buy Ecolab’s surgical products for nearly $1B
GE HealthCare's first quarter falls flat after China sales slide

Share This Article